Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves' Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00150111
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:34:48.925085+00:00
Published At
2006-10-06T00:00:00+00:00
Record Updated At
2006-10-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Graves\u00b4 Disease", "Thyroid Associated Ophthalmopathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2006-10-06"
protocolSection.identificationModule.nctId
"NCT00150111"
protocolSection.identificationModule.officialTitle
"B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves\u0027 Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Graves´ Disease (protocolSection.conditionsModule.conditions)
  • Thyroid Associated Ophthalmopathy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.